Dow Down 0.18% Nasdaq Down 0.33%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
1.69 Oct 29, 4:00PM EDT
Prev Close:1.69
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.96
Beta:2.57
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.00 - 8.46
Volume:0
Avg Vol (3m):2,229,620
Market Cap:102.15M
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNSS 0.00%102.15M
AZN90.34B
PFE186.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback